Results 201 to 210 of about 51,283 (222)
Some of the next articles are maybe not open access.
Structural Bioinformatics to Unveil Weaknesses of Coronavirus Spike Glycoprotein Stability
2021Alternative strategies for developing antiviral drugs are needed, as vaccines could not be the final answer against the present SARS CoV-2 outbreak, due to the still existing ambiguities in the immunological response to the virus. Thus, SARS CoV-2 enzymes have been thoroughly investigated to develop their inhibitors as antiviral drugs. We have searched
Bongini P. +4 more
openaire +2 more sources
Core Structure of S2 from the Human Coronavirus NL63 Spike Glycoprotein,
Biochemistry, 2006Human coronavirus NL63 (HCoV-NL63) has recently been identified as a causative agent of acute respiratory tract illnesses in infants and young children. The HCoV-NL63 spike (S) protein mediates virion attachment to cells and subsequent fusion of the viral and cellular membranes.
Zheng, Qi +5 more
openaire +2 more sources
Spike glycoprotein of coronavirus of animals and sars-Cov-2
Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases, 2022Bramhadev Pattnaik +8 more
openaire +1 more source
Sialoglycan binding triggers spike opening in a human coronavirus
Nature, 2023Matti F Pronker +2 more
exaly
Hematology and oncology clinical care during the coronavirus disease 2019 pandemic
Ca-A Cancer Journal for Clinicians, 2020Manish A Shah +2 more
exaly
Amyloid and Hydrogel Formation of a Peptide Sequence from a Coronavirus Spike Protein
ACS Nano, 2022Valeria Castelletto, Ian W Hamley
exaly
Planning for post‐pandemic cancer care delivery: Recovery or opportunity for redesign?
Ca-A Cancer Journal for Clinicians, 2021Pelin Cinar, Daniela A Bota, Emad Elquza
exaly
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Cell, 2020Alexandra C Walls +2 more
exaly